Organon & Co (OGN)
18.07
-0.71
(-3.78%)
USD |
NYSE |
Nov 01, 16:00
18.02
-0.05
(-0.28%)
After-Hours: 20:00
Organon Market Cap: 4.654B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 4.654B |
| October 31, 2024 | 4.837B |
| October 30, 2024 | 4.618B |
| October 29, 2024 | 4.597B |
| October 28, 2024 | 4.497B |
| October 25, 2024 | 4.419B |
| October 24, 2024 | 4.435B |
| October 23, 2024 | 4.432B |
| October 22, 2024 | 4.468B |
| October 21, 2024 | 4.494B |
| October 18, 2024 | 4.535B |
| October 17, 2024 | 4.543B |
| October 16, 2024 | 4.620B |
| October 15, 2024 | 4.646B |
| October 14, 2024 | 4.661B |
| October 11, 2024 | 4.636B |
| October 10, 2024 | 4.631B |
| October 09, 2024 | 4.643B |
| October 08, 2024 | 4.661B |
| October 07, 2024 | 4.667B |
| October 04, 2024 | 4.710B |
| October 03, 2024 | 4.703B |
| October 02, 2024 | 4.785B |
| October 01, 2024 | 4.849B |
| September 30, 2024 | 4.927B |
| Date | Value |
|---|---|
| September 27, 2024 | 4.938B |
| September 26, 2024 | 4.936B |
| September 25, 2024 | 4.900B |
| September 24, 2024 | 5.062B |
| September 23, 2024 | 5.077B |
| September 20, 2024 | 5.018B |
| September 19, 2024 | 5.196B |
| September 18, 2024 | 5.142B |
| September 17, 2024 | 5.291B |
| September 16, 2024 | 5.376B |
| September 13, 2024 | 5.270B |
| September 12, 2024 | 5.224B |
| September 11, 2024 | 5.191B |
| September 10, 2024 | 5.173B |
| September 09, 2024 | 5.196B |
| September 06, 2024 | 5.276B |
| September 05, 2024 | 5.500B |
| September 04, 2024 | 5.721B |
| September 03, 2024 | 5.685B |
| August 30, 2024 | 5.755B |
| August 29, 2024 | 5.744B |
| August 28, 2024 | 5.785B |
| August 27, 2024 | 5.770B |
| August 26, 2024 | 5.930B |
| August 23, 2024 | 5.757B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.799B
Minimum
Nov 16 2023
9.980B
Maximum
Mar 02 2022
6.494B
Average
6.174B
Median
Market Cap Benchmarks
| Eli Lilly and Co | 777.42B |
| Biomarin Pharmaceutical Inc | 12.69B |
| Cassava Sciences Inc | 1.257B |
| Ligand Pharmaceuticals Inc | 2.010B |
| TG Therapeutics Inc | 4.165B |
Market Cap Related Metrics
| PE Ratio | 3.585 |
| PS Ratio | 0.7283 |
| PEG Ratio | 0.0299 |
| Price to Book Value | 9.440 |
| Price to Free Cash Flow | 7.226 |
| Price | 18.07 |
| Earnings Yield | 27.89% |
| PEGY Ratio | 0.0284 |
| Operating PE Ratio | 3.108 |
| Normalized PE Ratio | 3.207 |